These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28238947)
41. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein. Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221 [TBL] [Abstract][Full Text] [Related]
42. Multidrug resistance-associated proteins 3, 4, and 5. Borst P; de Wolf C; van de Wetering K Pflugers Arch; 2007 Feb; 453(5):661-73. PubMed ID: 16586096 [TBL] [Abstract][Full Text] [Related]
43. Global Bayesian models for the prioritization of antitubercular agents. Prathipati P; Ma NL; Keller TH J Chem Inf Model; 2008 Dec; 48(12):2362-70. PubMed ID: 19053518 [TBL] [Abstract][Full Text] [Related]
45. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Akita H; Suzuki H; Hirohashi T; Takikawa H; Sugiyama Y Pharm Res; 2002 Jan; 19(1):34-41. PubMed ID: 11837698 [TBL] [Abstract][Full Text] [Related]
46. ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine. Shoji T; Suzuki H; Kusuhara H; Watanabe Y; Sakamoto S; Sugiyama Y Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G749-56. PubMed ID: 15217779 [TBL] [Abstract][Full Text] [Related]
47. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury. Yang K; Pfeifer ND; Köck K; Brouwer KL J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339 [TBL] [Abstract][Full Text] [Related]
48. Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide. Kimoto E; Li R; Scialis RJ; Lai Y; Varma MV Mol Pharm; 2015 Nov; 12(11):3943-52. PubMed ID: 26378985 [TBL] [Abstract][Full Text] [Related]
49. Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites. Létourneau IJ; Bowers RJ; Deeley RG; Cole SP Toxicol Lett; 2005 May; 157(1):9-19. PubMed ID: 15795089 [TBL] [Abstract][Full Text] [Related]
50. Efflux mechanism of taurocholate across the rat intestinal basolateral membrane. Sakamoto S; Suzuki H; Kusuhara H; Sugiyama Y Mol Pharm; 2006; 3(3):275-81. PubMed ID: 16749859 [TBL] [Abstract][Full Text] [Related]
51. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury. Li X; Zhong K; Guo Z; Zhong D; Chen X Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582 [TBL] [Abstract][Full Text] [Related]
53. The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole. Pan YQ; Mi QY; He BS; Zhao SL; Tai T; Xie HG Biopharm Drug Dispos; 2015 May; 36(4):232-44. PubMed ID: 25597959 [TBL] [Abstract][Full Text] [Related]
54. Exploring the structure-activity relationships of ABCC2 modulators using a screening approach. Wissel G; Kudryavtsev P; Ghemtio L; Tammela P; Wipf P; Yliperttula M; Finel M; Urtti A; Kidron H; Xhaard H Bioorg Med Chem; 2015 Jul; 23(13):3513-25. PubMed ID: 25935289 [TBL] [Abstract][Full Text] [Related]
55. Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay. Gilibili RR; Chatterjee S; Bagul P; Mosure KW; Murali BV; Mariappan TT; Mandlekar S; Lai Y Drug Metab Dispos; 2017 Jun; 45(6):604-611. PubMed ID: 28325716 [TBL] [Abstract][Full Text] [Related]
56. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Paumi CM; Wright M; Townsend AJ; Morrow CS Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885 [TBL] [Abstract][Full Text] [Related]
57. A predictive ligand-based Bayesian model for human drug-induced liver injury. Ekins S; Williams AJ; Xu JJ Drug Metab Dispos; 2010 Dec; 38(12):2302-8. PubMed ID: 20843939 [TBL] [Abstract][Full Text] [Related]
58. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247 [TBL] [Abstract][Full Text] [Related]
59. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury. Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392 [TBL] [Abstract][Full Text] [Related]
60. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]